Cointime

Download App
iOS & Android

Nasdaq-listed Anixa Biosciences board approves purchase of Bitcoin as reserve asset

Anixa Biosciences, a Nasdaq-listed company, has approved the purchase of Bitcoin as a reserve asset. The company also reiterated its ongoing stock buyback plan. Amit Kumar, CEO of the company, stated that the decision regarding Bitcoin is another way of prudent financial management and can achieve higher shareholder value. Anixa Biosciences is a biotechnology company focused on the treatment and prevention of cancer.

Comments

All Comments

Recommended for you